These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1721416)

  • 1. FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation.
    Tzakis AG; Abu-Elmagd K; Fung JJ; Bloom EJ; Nour B; Greif F; Starzl TE
    Transplant Proc; 1991 Dec; 23(6):3225-7. PubMed ID: 1721416
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of FK 506 for allogeneic bone marrow transplantation.
    Masaoka T; Shibata H; Kakishita E; Kanamaru A; Takemoto Y; Moriyama Y
    Transplant Proc; 1991 Dec; 23(6):3228-31. PubMed ID: 1721417
    [No Abstract]   [Full Text] [Related]  

  • 3. FK 506 reverses acute graft-versus-host disease after allogeneic bone marrow transplantation in rats.
    Markus PM; Cai X; Ming W; Demetris AJ; Fung JJ; Starzl TE
    Surgery; 1991 Aug; 110(2):357-63; discussion 363-4. PubMed ID: 1713358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506.
    Cooper MH; Hartman GG; Starzl TE; Fung JJ
    Transplant Proc; 1991 Dec; 23(6):3234-5. PubMed ID: 1721419
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of cyclosporine, rapamycin and FK 506 the survival following allogeneic bone marrow transplantation.
    Markus PM; Cai X; Selvaggi G; Cooper M; Harnaha J; Fung JJ; Starzl TE
    Transplant Proc; 1991 Dec; 23(6):3232-3. PubMed ID: 1721418
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolonged prevention of acute graft-versus-host disease after allogeneic bone marrow transplantation by donor pretreatment using FK 506.
    Cooper MH; Markus PM; Cai X; Starzl TE; Fung JJ
    Transplant Proc; 1991 Dec; 23(6):3238-9. PubMed ID: 1721421
    [No Abstract]   [Full Text] [Related]  

  • 7. Tacrolimus/Methotrexate versus cyclosporine/methotrexate as graft-versus-host disease prophylaxis in patients with severe aplastic anemia who received bone marrow transplantation from unrelated donors: results of matched pair analysis.
    Yagasaki H; Kojima S; Yabe H; Kato K; Kigasawa H; Sakamaki H; Tsuchida M; Kato S; Kawase T; Muramatsu H; Morishima Y; Kodera Y
    Biol Blood Marrow Transplant; 2009 Dec; 15(12):1603-8. PubMed ID: 19896085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine treatment of chronic graft-versus-host disease following allogeneic bone marrow transplantation.
    Sullivan KM; Siadak MF; Witherspoon RP
    Transplant Proc; 1990 Jun; 22(3):1336-8. PubMed ID: 2190396
    [No Abstract]   [Full Text] [Related]  

  • 9. FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantation.
    Fay JW; Nash RA; Wingard JR; Przepiorka D; Collins RH; Anasetti C; Devine SM; Piñeiro LA; Storb RF; Aro RM
    Transplant Proc; 1995 Feb; 27(1):1374. PubMed ID: 7533383
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of FK 506 in pediatric patients.
    Tzakis AG; Fung JJ; Todo S; Reyes J; Green M; Starzl TE
    Transplant Proc; 1991 Feb; 23(1 Pt 2):924-7. PubMed ID: 1703353
    [No Abstract]   [Full Text] [Related]  

  • 11. FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donors.
    Storb R; Raff RF; Appelbaum FR; Deeg HJ; Fitzsimmons W; Graham TC; Pepe M; Pettinger M; Sale G; van der Jagt R
    Transplantation; 1993 Oct; 56(4):800-7. PubMed ID: 7692635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus.
    Eckardt A; Starke O; Stadler M; Reuter C; Hertenstein B
    Oral Oncol; 2004 Sep; 40(8):811-4. PubMed ID: 15288836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic graft-versus-host disease, obliterative bronchiolitis, and graft-versus-leukemia effect: case histories.
    Sullivan KM; Shulman HM
    Transplant Proc; 1989 Jun; 21(3 Suppl 1):51-62. PubMed ID: 2662536
    [No Abstract]   [Full Text] [Related]  

  • 14. Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation.
    Przepiorka D; Ippoliti C; Khouri I; Woo M; Mehra R; Le Bherz D; Giralt S; Gajewski J; Fischer H; Fritsche H; Deisseroth AB; Cleary K; Champlin R; Besien K; Andersson B; Maher R; Fitzsimmons W
    Blood; 1996 Dec; 88(11):4383-9. PubMed ID: 8943876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation.
    Koehler MT; Howrie D; Mirro J; Neudorf S; Blatt J; Corey S; Wollman M; Kelly-Ekeroth V; Reyes J
    Bone Marrow Transplant; 1995 Jun; 15(6):895-9. PubMed ID: 7581088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.
    Ratanatharathorn V; Nash RA; Przepiorka D; Devine SM; Klein JL; Weisdorf D; Fay JW; Nademanee A; Antin JH; Christiansen NP; van der Jagt R; Herzig RH; Litzow MR; Wolff SN; Longo WL; Petersen FB; Karanes C; Avalos B; Storb R; Buell DN; Maher RM; Fitzsimmons WE; Wingard JR
    Blood; 1998 Oct; 92(7):2303-14. PubMed ID: 9746768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of disfiguring chronic graft versus host disease in a child with topical pimecrolimus.
    Zangrilli A; Campione E; Diluvio L; Paternò EJ; Orlandi A; Simone MD; Chimenti S
    Pediatr Int; 2010 Jun; 52(3):e161-3. PubMed ID: 20723118
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporine as an alternative to cyclophosphamide in the treatment of chronic graft-versus-host disease.
    Bunjes D; Heit W; Arnold R; Schmeiser T; Heimpel H
    Transplantation; 1986 Feb; 41(2):170-2. PubMed ID: 3511579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute graft-versus-host disease after allogeneic marrow transplantation. Randomized study comparing corticosteroids and cyclosporine.
    Kennedy MS; Deeg HJ; Storb R; Doney K; Sullivan KM; Witherspoon RP; Appelbaum FR; Stewart P; Sanders J; Buckner CD
    Am J Med; 1985 Jun; 78(6 Pt 1):978-83. PubMed ID: 3893112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow augmentation in kidney transplantation: a large animal study.
    Gruessner RW; Zhang KY; Dunning M; Nakhleh RE; Gruessner AC
    Transpl Int; 2001 Jun; 14(3):159-69. PubMed ID: 11499905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.